Emerald Health Therapeutics Inc. is committed to cutting-edge cannabis science to create new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products. With an emphasis on innovation and production excellence, Emerald’s three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities. These assets, all in full production include: its Richmond, BC-based greenhouse operation (78,000 square feet) capable of producing organic-certified product; Verdélite, its premium craft cannabis production indoor facility in St. Eustache, Québec (88,000 square foot); and Pure Sunfarms, its 41.3%-owned joint venture in Delta, BC, producing high quality, affordably priced products (1.1 million square feet). Its Emerald Naturals joint venture has launched a new natural wellness product category with its non-cannabis endocannabinoid-supporting product line and is expanding distribution across Canada.
Company profile
Ticker
EMHTF
Exchange
Website
CEO
Avtar S. Dhillon
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
EMHTF stock data
Latest filings (excl ownership)
15-15D
Suspension of duty to report
1 Apr 21
RW
Registration withdrawal request
29 Mar 21
6-K
Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis
17 Mar 21
6-K
Emerald Health Therapeutics Announces Intention to List on Canadian Securities Exchange
10 Mar 21
6-K
Current report (foreign)
18 Feb 21
6-K
Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans
9 Feb 21
6-K
Current report (foreign)
5 Feb 21
6-K
Current report (foreign)
13 Jan 21
6-K
Emerald Health Therapeutics' Partner STENOCARE Makes First Delivery of Medical Cannabis Oil to Swedish Patients
29 Dec 20
6-K
Current report (foreign)
17 Dec 20
Latest ownership filings
No filings
Financial summary
Annual (USD) | Dec 19 | Dec 18 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |